| Ações em Circulação | 278,291,590 shares |
| Ações de Insider | 93,665,391 shares |
| Propriedade de Insider | 33.66 % |
| Total de Insiders | 23 |
Pontuação de Sentimento de Insider
A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.
É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.
Frequência de Atualização: Diariamente
Pontuação de Sentimento dos Oficiais
A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.
Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.
Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.
Frequência de Atualização: Diariamente
Principais Métricas de Insider
Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.
Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).
Percentual do Float Comprado por Insiders (Classificação)
5373 out of 10786
Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.
Gráfico de Negociação de Insider
Sana Biotechnology, Inc. negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.
Roster de Insider e Métricas de Lucratividade
Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Lucro Médio (%) | Ações Possuídas |
Ajuste de Divisão |
|---|---|---|---|
|
Noubar Afeyan
10% Owner -
|
11,585,199 | 0 | |
| Sunil Agarwal EVP, Head of Development & CMO - [O] | 1,550,000 | 1,550,000 | |
|
ARCH Venture Fund X, L.P.
10% Owner -
|
22,747,272 | 22,747,272 | |
|
ARCH Venture Partners X, LLC
10% Owner -
|
11,718,750 | 22,747,272 | |
| Bilenker Joshua H. Director - [D] | 20,000 | 20,000 | |
| Hans Edgar Bishop Director - [D] | 5,848,503 | 5,848,503 | |
|
Keith Crandell
10% Owner -
|
22,747,272 | 22,747,272 |
| Insider | Lucro Médio (%) | Ações Possuídas |
Ajuste de Divisão |
|---|---|---|---|
| Bernard J Cassidy EVP & General Counsel - [O] | 112,990 | 112,990 | |
|
FMR LLC / Fidelity Management & Research
10% Owner -
|
4,541,572 | 4,541,572 | |
|
Flagship Ventures Fund V General Partner LLC
10% Owner -
|
22,546,725 | 0 | |
|
Flagship Ventures Management, Inc.
10% Owner -
|
0 | 0 | |
|
Steven Gillis
10% Owner -
|
11,718,750 | 22,747,272 | |
| Nathan Hardy SVP, Chief Financial Officer - [O] | 511,250 | 511,250 | |
| Steve Harr President & CEO, Director - [D] [O] | 7,944,251 | 7,944,251 | |
| Christian Hordo EVP, Chief Business Officer - [O] | 867,455 | 867,455 |
| Insider | Lucro Médio (%) | Ações Possuídas |
Ajuste de Divisão |
|---|---|---|---|
| MacDonald James J. EVP & General Counsel - [O] | 497,396 | 497,396 | |
| Richard Mulligan Director - [D] | 2,698,121 | 2,698,121 | |
|
Robert Nelsen
Director, 10% Owner -
[D]
|
22,761,125 | 22,761,125 | |
| Dhavalkumar Dhirajlal Patel EVP, Chief Scientific Officer - [O] | 99,510 | 99,510 | |
| Mary Agnes Wilderotter Director - [D] | 7,106 | 7,106 | |
| Wyrick Susan D. See Remarks - [O] | 196,196 | 196,196 | |
| Patrick Y Yang Director - [D] | 149,250 | 149,250 | |
| Maltzahn Geoffrey von Director - [D] | 366,122 | 366,122 |
Report errors via our new Insider Auditing Tool
Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em SANA / Sana Biotechnology, Inc.. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .
A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.
Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.
Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo
Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em SANA / Sana Biotechnology, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .
A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.
Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.
Histórico de Transações
Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.
| Arquivo Data |
Data da Operação |
Formulário | Insider | Ticker | Título de Segurança | Código | Direto | Preço de Exercício Preço Unitário |
Preço por Unidade |
Unidades Alteradas |
Valor Alterado (1K) |
Opções Restantes |
Ações Restantes |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | 2026-04-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7,763 | 5,848,503 | ||||||
| 2026-03-27 | 3 | PATEL DHAVALKUMAR DHIRAJLAL | SANA | Common Stock | D | 99,510 | ||||||||
| 2026-03-10 | 2026-03-09 | 4 | Harr Steve | SANA | Common Stock | D | 3.1000 | -12,819 | -40 | 7,944,251 | ||||
| 2026-03-10 | 2026-03-09 | 4 | Harr Steve | SANA | Common Stock | D | 3.1300 | -11,526 | -36 | 7,957,070 | ||||
| 2026-03-10 | 2026-03-07 | 4 | Harr Steve | SANA | Common Stock | D | 50,000 | 7,968,596 | ||||||
| 2026-03-10 | 2026-03-06 | 4 | Harr Steve | SANA | Common Stock | D | 41,666 | 7,918,596 | ||||||
| 2026-03-10 | 2026-03-09 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3.1000 | -1,045 | -3 | 196,196 | ||||
| 2026-03-10 | 2026-03-09 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3.1300 | -3,342 | -10 | 197,241 | ||||
| 2026-03-10 | 2026-03-07 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,250 | 200,583 | ||||||
| 2026-03-10 | 2026-03-06 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10,416 | 197,333 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3.9100 | -491 | -2 | 186,917 | ||||
| 2026-03-04 | 2026-03-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1,525 | 187,408 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6,157 | 5,840,740 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 4.2700 | -2,407 | -10 | 185,883 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 7,500 | 188,290 | ||||||
| 2025-12-16 | 2025-12-15 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 5.2200 | -873 | -5 | 180,790 | ||||
| 2025-12-16 | 2025-12-13 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,400 | 181,663 | ||||||
| 2025-12-05 | 2025-12-04 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 4.4400 | -2,565 | -11 | 178,263 | ||||
| 2025-12-05 | 2025-12-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10,000 | 180,828 | ||||||
| 2025-12-05 | 2025-06-04 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2.3200 | -2,567 | -6 | 167,828 | ||||
| 2025-12-05 | 2025-06-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10,000 | 170,395 | ||||||
| 2025-10-07 | 2025-10-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 5,628 | 5,834,583 | ||||||
| 2025-07-08 | 2025-07-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7,842 | 5,828,955 | ||||||
| 2025-04-08 | 2025-04-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 16,339 | 5,821,113 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Harr Steve | SANA | Common Stock | D | 2.5600 | -12,820 | -33 | 7,876,930 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Harr Steve | SANA | Common Stock | D | 50,000 | 7,889,750 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Cassidy Bernard J | SANA | Common Stock | D | 2.5600 | -2,833 | -7 | 112,990 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Cassidy Bernard J | SANA | Common Stock | D | 11,041 | 115,823 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2.5600 | -836 | -2 | 157,395 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,250 | 158,231 | ||||||
| 2025-03-03 | 2025-03-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2.5600 | -490 | -1 | 154,981 | ||||
| 2025-03-03 | 2025-03-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1,525 | 155,471 | ||||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 7.2600 | -1,000 | -7 | 4,541,511 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6.7100 | -164,912 | -1,107 | 4,542,511 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6.5000 | -25,000 | -162 | 4,707,423 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6.1100 | -100,000 | -611 | 4,732,423 | ||||
| 2025-01-07 | 2025-01-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 14,285 | 5,804,774 | ||||||
| 2025-01-03 | 2025-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1.6500 | -1,566 | -3 | 153,946 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 5,000 | 155,512 | ||||||
| 2024-11-21 | 3/A | FMR LLC / Fidelity Management & Research FMR Capital, Inc. | SANA | Common Stock | I | 61 | ||||||||
| 2024-10-15 | 3 | Wyrick Susan D. | SANA | Common Stock | D | 147,512 | ||||||||
| 2024-10-09 | 2024-10-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 5,938 | 5,790,489 | ||||||
| 2024-09-26 | 2024-09-25 | 4 | Mulligan Richard | SANA | Common Stock | D | 3.8878 | -150,000 | -583 | 2,698,121 | ||||
| 2024-09-26 | 2024-09-24 | 4 | Mulligan Richard | SANA | Common Stock | D | 4.0838 | -150,000 | -613 | 2,848,121 | ||||
| 2024-07-08 | 2024-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4,911 | 5,784,551 | ||||||
| 2024-04-08 | 2024-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2,774 | 5,779,640 | ||||||
| 2024-04-08 | 3 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 4,832,423 | ||||||||
| 2024-03-11 | 2024-03-08 | 4 | Yang Patrick Y | SANA | Common Stock | D | 9.4520 | -25,000 | -236 | 149,250 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5.5000 | 727,272 | 4,000 | 12,446,022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5.5000 | 727,272 | 4,000 | 12,446,022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5.5000 | 363,637 | 2,000 | 10,667,387 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5.5000 | 727,272 | 4,000 | 12,446,022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5.5000 | 727,272 | 4,000 | 12,446,022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5.5000 | 363,637 | 2,000 | 10,667,387 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5.5000 | 727,272 | 4,000 | 12,446,022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5.5000 | 727,272 | 4,000 | 12,446,022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5.5000 | 363,637 | 2,000 | 10,667,387 | ||||
| 2024-01-08 | 2024-01-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 1,470 | 7,106 | ||||||
| 2024-01-08 | 2024-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4,901 | 5,776,866 | ||||||
| 2023-12-18 | 2023-12-15 | 4 | Hordo Christian | SANA | Common Stock | D | 4.0013 | -75,000 | -300 | 867,455 | ||||
| 2023-10-06 | 2023-10-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6,925 | 5,771,965 | ||||||
| 2023-10-06 | 2023-10-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 2,077 | 5,636 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI General Partner LLC | SANA | Common Stock | I | -70,813 | 0 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI, L.P. | SANA | Common Stock | I | -2,431,281 | 7,293,841 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Ventures Fund V General Partner LLC | SANA | Common Stock | I | -1,181,745 | 0 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | -345,069 | 1,035,208 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | -4,926,378 | 8,057,470 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship VentureLabs V, LLC | SANA | Common Stock | I | -2,825,989 | 8,615,337 | ||||||
| 2023-07-06 | 2023-07-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 1,245 | 3,559 | ||||||
| 2023-07-06 | 2023-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4,152 | 5,765,040 | ||||||
| 2023-06-08 | 2023-06-07 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6.2397 | -22,760 | -142 | 1,380,277 | ||||
| 2023-06-08 | 2023-06-07 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6.2397 | -177,240 | -1,106 | 10,743,293 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6.3061 | -22,297 | -141 | 1,403,037 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6.3061 | -181,461 | -1,144 | 10,920,533 | ||||
| 2023-05-26 | 2023-05-26 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6.2265 | -9,330 | -58 | 1,425,334 | ||||
| 2023-05-26 | 2023-05-26 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6.2265 | -72,670 | -452 | 11,101,994 | ||||
| 2023-05-26 | 2023-05-25 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6.3522 | -13,127 | -83 | 1,434,664 | ||||
| 2023-05-26 | 2023-05-25 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6.3522 | -102,245 | -649 | 11,174,664 | ||||
| 2023-05-26 | 2023-05-24 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6.5652 | -39,580 | -260 | 1,447,791 | ||||
| 2023-05-26 | 2023-05-24 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6.5652 | -308,290 | -2,024 | 11,276,909 | ||||
| 2023-04-06 | 2023-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7,716 | 5,760,888 | ||||||
| 2023-04-06 | 2023-04-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 2,314 | 2,314 | ||||||
| 2023-02-17 | 2021-02-03 | 4 | Bilenker Joshua H. | SANA | Common Stock | D | 25.0000 | 20,000 | 500 | 20,000 | ||||
| 2023-01-06 | 2023-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6,702 | 5,753,172 | ||||||
| 2023-01-06 | 2023-01-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 536 | 1,353 | ||||||
| 2022-10-06 | 2022-10-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 321 | 817 | ||||||
| 2022-10-06 | 2022-10-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4,012 | 5,746,470 | ||||||
| 2022-09-20 | 3/A | Cassidy Bernard J | SANA | Common Stock | D | 92,781 | ||||||||
| 2022-09-16 | 3 | Cassidy Bernard J | SANA | Common Stock | D | 82,031 | ||||||||
| 2022-07-07 | 2022-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 3,328 | 5,742,458 | ||||||
| 2022-07-07 | 2022-07-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 266 | 496 | ||||||
| 2022-06-15 | 2022-06-13 | 4 | MacDonald James J. | SANA | Common Stock | D | 1.4800 | 66,796 | 99 | 497,396 | ||||
| 2022-06-15 | 2022-05-13 | 4 | MacDonald James J. | SANA | Common Stock | D | 4.2840 | 1,183 | 5 | 430,600 | ||||
| 2022-04-15 | 2021-04-14 | 4 | Harr Steve | SANA | Common Stock | D | -167,000 | 7,839,750 | ||||||
| 2022-04-15 | 2021-04-14 | 4 | Harr Steve | SANA | Common Stock | D | -167,000 | 7,839,750 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2,880 | 5,739,130 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 230 | 230 | ||||||
| 2022-03-22 | 2022-03-21 | 4 | Yang Patrick Y | SANA | Common Stock | D | 7.3000 | 28,000 | 204 | 174,250 | ||||
| 2022-03-08 | 2022-03-03 | 4 | Harr Steve | SANA | Stock Options (Right to Buy) | D | 5.70 | 760,000 | 760,000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | AGARWAL SUNIL | SANA | Stock Options (Right to Buy) | D | 5.70 | 250,000 | 250,000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Mulligan Richard | SANA | Stock Options (Right to Buy) | D | 5.70 | 250,000 | 250,000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Hordo Christian | SANA | Stock Options (Right to Buy) | D | 5.70 | 225,000 | 225,000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | MacDonald James J. | SANA | Stock Options (Right to Buy) | D | 5.70 | 225,000 | 225,000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Hardy Nathan | SANA | Stock Options (Right to Buy) | D | 5.70 | 225,000 | 225,000 | |||||
| 2022-02-23 | 2022-02-18 | 4 | MacDonald James J. | SANA | Common Stock | D | 6.2800 | -333 | -2 | 429,417 | ||||
| 2022-02-23 | 2021-11-15 | 4 | MacDonald James J. | SANA | Common Stock | D | 18.2325 | 1,000 | 18 | 429,750 | ||||
| 2021-09-17 | 2021-09-16 | 4 | AGARWAL SUNIL | SANA | Common Stock | D | 26.0000 | -1,627 | -42 | 1,550,000 | ||||
| 2021-09-17 | 2021-09-15 | 4 | AGARWAL SUNIL | SANA | Common Stock | D | 26.0695 | -58,373 | -1,522 | 1,551,627 | ||||
| 2021-09-14 | 2021-09-10 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0000 | -1,477 | -37 | 942,455 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1.48 | -39,205 | 88,803 | |||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0081 | -25,466 | -637 | 943,932 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0130 | -39,205 | -981 | 969,398 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 1.4800 | 39,205 | 58 | 1,008,603 | ||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1.48 | -700 | 128,008 | |||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0000 | -700 | -18 | 969,398 | ||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Common Stock | D | 1.4800 | 700 | 1 | 970,098 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1.48 | -6,558 | 128,708 | |||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0039 | -1,400 | -35 | 969,398 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0019 | -6,558 | -164 | 970,798 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 1.4800 | 6,558 | 10 | 977,356 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1.48 | -1,134 | 135,266 | |||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0057 | -3,002 | -75 | 970,798 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0036 | -1,134 | -28 | 973,800 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 1.4800 | 1,134 | 2 | 974,934 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1.48 | -1,100 | 136,400 | |||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0183 | -1,200 | -30 | 973,800 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 25.0100 | -1,100 | -28 | 975,000 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 1.4800 | 1,100 | 2 | 976,100 | ||||
| 2021-04-27 | 2021-04-21 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 12,500 | 12,500 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2,343,750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2,343,750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781,250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781,250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9,375,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9,375,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11,718,750 | 11,718,750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11,718,750 | 11,718,750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10,156,250 | 10,301,250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10,156,250 | 10,301,250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2,343,750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2,343,750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781,250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781,250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9,375,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9,375,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11,718,750 | 11,718,750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11,718,750 | 11,718,750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10,156,250 | 10,301,250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10,156,250 | 10,301,250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -11,585,199 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -11,441,326 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9,725,122 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -1,487,371 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 11,585,199 | 11,585,199 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 11,441,326 | 11,441,326 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 9,725,122 | 9,725,122 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 1,487,371 | 1,487,371 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series B Convertible Preferred Stock | D | -156,250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series A-2 Convertible Preferred Stock | D | -800,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series A-1 Convertible Preferred Stock | D | -1,075,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2,031,250 | 5,736,250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2,343,750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2,343,750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781,250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781,250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9,375,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9,375,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3,687,500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 11,718,750 | 11,718,750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 11,718,750 | 11,718,750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 10,156,250 | 10,301,250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 10,156,250 | 10,301,250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT | SANA | Series A-2 Convertible Preferred Stock | I | -366,122 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey | SANA | Series A-2 Convertible Preferred Stock | D | -1,464,488 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT | SANA | Common Stock | I | 366,122 | 366,122 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey | SANA | Common Stock | D | 1,464,488 | 1,464,488 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series B Convertible Preferred Stock | D | -156,250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series A-2 Convertible Preferred Stock | D | -800,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series A-1 Convertible Preferred Stock | D | -1,075,000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Common Stock | D | 2,031,250 | 8,173,750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 | SANA | Series B Convertible Preferred Stock | I | -7,812 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. | SANA | Series A-1 Convertible Preferred Stock | D | -93,750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 | SANA | Common Stock | I | 7,812 | 7,812 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. | SANA | Common Stock | D | 93,750 | 428,750 | ||||||
| 2021-02-05 | 2021-02-03 | 4 | NELSEN ROBERT | SANA | Stock Option (Right to Buy) | D | 25.00 | 14,000 | 14,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | von Maltzahn Geoffrey | SANA | Stock Option (Right to Buy) | D | 25.00 | 14,000 | 14,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Bishop Hans Edgar | SANA | Stock Option (Right to Buy) | D | 25.00 | 14,000 | 14,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | AGARWAL SUNIL | SANA | Stock Option (Right to Buy) | D | 25.00 | 48,000 | 48,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Bilenker Joshua H. | SANA | Stock Option (Right to Buy) | D | 25.00 | 7,000 | 7,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Cole Douglas G. | SANA | Stock Option (Right to Buy) | D | 25.00 | 14,000 | 14,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Wilderotter Mary Agnes | SANA | Stock Option (Right to Buy) | D | 25.00 | 14,000 | 14,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Seitz Michelle | SANA | Stock Option (Right to Buy) | D | 25.00 | 7,000 | 7,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Yang Patrick Y | SANA | Stock Option (Right to Buy) | D | 25.00 | 14,000 | 14,000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | REICIN ALISE | SANA | Stock Option (Right to Buy) | D | 25.00 | 7,000 | 7,000 | |||||
| 2021-02-03 | 3 | AGARWAL SUNIL | SANA | Common Stock | D | 1,610,000 | ||||||||
| 2021-02-03 | 3 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 147,500 | ||||||||
| 2021-02-03 | 3 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 145,000 | ||||||||
| 2021-02-03 | 3 | GILLIS STEVEN See Footnotes | SANA | Common Stock | I | 145,000 | ||||||||
| 2021-02-03 | 3 | GILLIS STEVEN See Footnotes | SANA | Common Stock | I | 147,500 | ||||||||
| 2021-02-03 | 3 | ARCH Venture Partners X, LLC See Footnotes | SANA | Common Stock | I | 145,000 | ||||||||
| 2021-02-03 | 3 | ARCH Venture Partners X, LLC See Footnotes | SANA | Common Stock | I | 147,500 | ||||||||
| 2021-02-03 | 3 | Hordo Christian | SANA | Common Stock | D | 975,000 | ||||||||
| 2021-02-03 | 3 | Yang Patrick Y | SANA | Common Stock | D | 146,250 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. | SANA | Common Stock | D | 335,000 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. Held by the KOM Trust | SANA | Common Stock | I | 125,000 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. Held by the NMM Trust | SANA | Common Stock | I | 125,000 | ||||||||
| 2021-02-03 | 3 | Mulligan Richard | SANA | Common Stock | D | 2,998,121 | ||||||||
| 2021-02-03 | 3 | Harr Steve Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015 | SANA | Common Stock | I | 682,500 | ||||||||
| 2021-02-03 | 3 | Harr Steve | SANA | Common Stock | D | 6,142,500 | ||||||||
| 2021-02-03 | 3 | Bishop Hans Edgar | SANA | Common Stock | D | 3,705,000 | ||||||||
| 2021-02-03 | 3 | Hardy Nathan | SANA | Common Stock | D | 511,250 |
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
